
|Articles|January 1, 2008
Ideal length of androgen ablation for treatment of prostate cancer still debated
Although the observation is awaiting confirmation by more definitive data, it may be that in a select group of radiation-treated prostate cancer patients, 6 months of androgen ablation is as effective as a 3-year course of the adjuvant therapy in terms of cancer-specific survival.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Experts urge FDA to revisit labeling for testosterone replacement therapy in men
2
Sildenafil cream for female sexual arousal disorder available to prescribe in select states
3
FDA approves first-line Zenflow system for the treatment of BPH
4
FDA approves gepotidacin for uncomplicated urogenital gonorrhea
5
















